相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib
Teemu P. Miettinen et al.
EMBO JOURNAL (2018)
Hallmarks of Cellular Senescence
Alejandra Hernandez-Segura et al.
TRENDS IN CELL BIOLOGY (2018)
Therapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosus
Chi Chiu Mok
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Palbociclib-induced autophagy and senescence in gastric cancer cells
Claudio A. Valenzuela et al.
EXPERIMENTAL CELL RESEARCH (2017)
CDK4/6 inhibition triggers anti-tumour immunity
Shom Goel et al.
NATURE (2017)
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival
Haizhen Wang et al.
NATURE (2017)
Inhibition of proliferation and invasion in 2D and 3D models by 2-methoxyestradiol in human melanoma cells
R. R. Massaro et al.
PHARMACOLOGICAL RESEARCH (2017)
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
Smruthi Vijayaraghavan et al.
NATURE COMMUNICATIONS (2017)
15,16-dihydrotanshinone I Induces Apoptosis and Inhibits the Proliferation, Migration of Human Osteosarcoma Cell Line 143B in vitro
Xuepeng Chen et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells
Liang Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Lysosomes as mediators of drug resistance in cancer
Benny Zhitomirsky et al.
DRUG RESISTANCE UPDATES (2016)
Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment
Todd VanArsdale et al.
CLINICAL CANCER RESEARCH (2015)
FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2015)
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Nicolas Herranz et al.
NATURE CELL BIOLOGY (2015)
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
Remi-Martin Laberge et al.
NATURE CELL BIOLOGY (2015)
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
Olga V. Leontieva et al.
ONCOTARGET (2015)
Evaluation of Acridine Orange, LysoTracker Red, and Quinacrine as Fluorescent Probes for Long-Term Tracking of Acidic Vesicles
Agnieszka Pierzynska-Mach et al.
CYTOMETRY PART A (2014)
Cellular senescence: from physiology to pathology
Daniel Munoz-Espin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence Duration of cell cycle arrest and MTOR activity determine geroconversion
Olga V. Leontieva et al.
CELL CYCLE (2013)
RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs
Tyler J. W. Robinson et al.
PLOS ONE (2013)
Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
Faraz Kazmi et al.
DRUG METABOLISM AND DISPOSITION (2013)
Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications
Randall Logan et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
The profile of lysosomal exoglycosidases in replicative and stress-induced senescence in early passage human fibroblasts
Malgorzata Knas et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2012)
E2F1-dependent oncogenic addiction of melanoma cells to MDM2
M. Verhaegen et al.
ONCOGENE (2012)
p53 Dynamics Control Cell Fate
Jeremy E. Purvis et al.
SCIENCE (2012)
Senescence: a new weapon for cancer therapy
Juan Carlos Acosta et al.
TRENDS IN CELL BIOLOGY (2012)
A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
Lars Anders et al.
CANCER CELL (2011)
The Role of Lysosomes in Limiting Drug Toxicity in Mice
Rosemary A. Ndolo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Therapy-Induced Senescence in Cancer
Jonathan A. Ewald et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Inflammatory networks during cellular senescence: causes and consequences
Adam Freund et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Modulation of the Partition Coefficient between Octanol and Buffer at pH 7.4 and pKa to Achieve the Optimum Balance of Blood Clearance and Volume of Distribution for a Series of Tetrahydropyran Histamine Type 3 Receptor Antagonists
Tanya Hay et al.
DRUG METABOLISM AND DISPOSITION (2009)
Mechanisms of amine accumulation in, and egress from, lysosomes
Stephen D. B. Goldman et al.
BIOANALYSIS (2009)
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH (2009)
Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions
Joni J. Palmgren et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Contribution of lysosomes to concentrative uptake of DX-9065a into rat liver
Nobuyuki Murayama et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
M Narita et al.
CELL (2003)
Mechanisms of cellular distribution of psychotropic, drugs. Significance for drug action and interactions
WA Daniel
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Oncogenic ras and p53 cooperate to induce cellular senescence
G Ferbeyre et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
分享论文
